Skip to main content
Clinical Trials/DRKS00021471
DRKS00021471
Completed
Phase 3

Telemetric monitoring of blood pressure treatment in patients with inadequately treated hypertension

ephrologisches Zentrum Göttingen0 sites60 target enrollmentApril 22, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
I10.0
Sponsor
ephrologisches Zentrum Göttingen
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 22, 2020
End Date
August 1, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ephrologisches Zentrum Göttingen

Eligibility Criteria

Inclusion Criteria

  • Age\> 18 years \<80 years
  • \- 24\-hour RR mean (ABDM)\> 130/80 mmHg
  • \- A written declaration of consent is available

Exclusion Criteria

  • \- insufficient psychological resilience (psychiatric treatment)
  • \- renal artery stenosis
  • \- Pregnancy
  • \- Pheochromocytoma
  • \- malignant hypertension
  • \- acute kidney failure
  • \- terminal renal failure (creatinine clearance \<20 ml / min)
  • \- cerebrovascular events
  • \- hypertensive encephalopathy
  • \- Heart attack in the past 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials